VPTDF News 0.0704 Ventripoint Diagnostics Ltd. (VPTDF)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ventripoint Diagnostics Ltd. (VPTDF) 0.0704 $VPTDF

Ventripoint Corporate Update and Resignation of Director
Marketwire - Tue Apr 08, 7:54AM CDT
Ventripoint Diagnostics Ltd. ("Ventripoint" (TSX VENTURE: VPT) announces that following the clearance by the US Food and Drug Administration (FDA) of the VMS(TM) heart analysis system for right ventricle assessment in adult patients with Pulmonary Arterial Hypertension (PAH), the Company has focused on initial marketing strategies which include:

Ventripoint VMS(TM) Heart Analysis System Used to Monitor Therapy in Pulmonary Hypertension and Valve Replacement in Congenital Heart Disease
Marketwire - Wed Apr 02, 2:28PM CDT
Ventripoint Diagnostics Ltd. ("Ventripoint" (TSX VENTURE: VPT) announces that following the clearance by the US Food and Drug Administration (FDA) of the VMS(TM) heart analysis system for right ventricle assessment in adult patients with Pulmonary Arterial Hypertension (PAH), the Company has focused on advancing marketing strategies, furthering partnership discussions for technology integration and establishing clinical studies to broaden the application of the VMS. We report today on the completion of two studies, one in PAH and one in congenital heart disease. Both studies verify the utility of the VMS(TM) in monitoring patients after treatment to determine if the therapy has been effective.

IIROC Trade Resumption - VentriPoint Diagnostics Ltd.
Newsfile Corp - Mon Mar 10, 8:35AM CDT
Trading resumes in:

FDA Clears Ventripoint VMS(TM) Heart Analysis System for Use in Patients with Pulmonary Arterial Hypertension
Marketwire - Mon Mar 10, 7:24AM CDT
Ventripoint Diagnostics Ltd. ("Ventripoint" (TSX VENTURE: VPT) announces that the US Food and Drug Administration (FDA) has cleared the VMS(TM) heart analysis system to be an adjunct to all existing 2D ultrasound imaging devices to allow computation of the 3D volume and ejection fraction of the right heart in patients with Pulmonary Arterial Hypertension (PAH).

IIROC Trade Halt - VentriPoint Diagnostics Ltd.
Newsfile Corp - Fri Mar 07, 2:55PM CST
The following issues have been halted by IIROC:

Oculus Innovative Sciences, Inc. to Raise $1.35 Million in Registered Direct Offering
GlobeNewswire - Fri Feb 21, 9:00PM CST
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced today that it has entered into definitive agreements with two life sciences-focused institutional investors for the sale of 450,620 units, consisting of shares of common stock, and Series A and Series B warrants, at a per unit price of $3.00 per share. The total amount sold consisted of a combination of: (1) 450,620 shares of its common stock; (2) Series A warrants to purchase up to 450,620 shares of common stock at an exercise price of $3.00 per share and a term of five years; and (3) Series B warrants to purchase up to 1,400,000 shares of common stock at an exercise price of $3.63 per share. The Series B warrants are not exercisable for six months following the closing of the IPO and have a term of 18 months. The Series B warrants have not vested and will not vest until the completion of the initial public offering (IPO) by the company's subsidiary, Ruthigen, Inc. The Series B warrants terminate on March 31, 2014, if the Ruthigen IPO has not occurred by that date.

Ventripoint Announces 510(k) Submission for VMS Heart Analysis System and Issuance of Shares for Debt
Marketwire - Thu Jan 23, 6:01AM CST
Ventripoint Diagnostics Ltd. (TSX VENTURE: VPT) is pleased to announce that it has submitted to the US Federal Drug Administration ("the Agency" a new 510(k) for clearance for the VMS(TM) heart analysis system for use in Pulmonary Arterial Hypertension (PAH).

Yieldex Wraps Up 2013 With 1.5 Trillion Impressions
Marketwire - Thu Dec 19, 8:30AM CST
Yieldex, the leading provider of inventory and revenue management solutions for digital publishers, today announced that 1.5 trillion ad impressions have been analyzed via the YieldEdge platform this year, demonstrating that companies are increasing their investment and reliance on big data analytics to grow their businesses.

Ventripoint Announces Regulatory Update for VMS(tm) Heart Analysis System
ACCESSWIRE - Fri Dec 13, 4:29PM CST
Seattle, Washington, December 13, 2013 - Ventripoint Diagnostics Ltd. (TSXV:VPT) (the Company or Ventripoint) is pleased to announce that the it has responded within the specified 30-day period to the non-substantially equivalent (NSE) letter received from the U.S. FDA on November 14, 2013, and has had numerous discussions with the FDA to identify the best and quickest pathway to obtain clearance for the VMS(TM) heart analysis system for use in Pulmonary Arterial Hypertension (PAH).

Ventripoint Announces Planned Response to FDA Notification and Expanded Sales Efforts Outside of the United States
ACCESSWIRE - Mon Nov 25, 3:11PM CST
** FDA has Invited the Company to Meet the Review Team **

Ventripoint Receives Response from FDA for Application of VMS (tm) for use in Pulmonary Arterial Hypertension
ACCESSWIRE - Fri Nov 15, 8:02AM CST
Seattle, Washington, November 15, 2013 - Ventripoint Diagnostics Ltd. ("Ventripoint" (TSXV:VPT) announces that the FDA has closed its review of the Company's 510(K) application for approval of the Ventripoint Medical System (VMS(TM)) for use in Pulmonary Arterial Hypertension (PAH). The FDA has found that despite achieving an average agreement between VMS and MRI results within the allowable 10% mean difference, the substantial equivalency was not sufficiently proven to warrant approval. The FDA stated that Ventripoint is welcome to submit a new 510(K) application with data that would show substantial equivalency.

IIROC: Halt; VentriPoint Diagnostics Ltd.
Marketwire Canada - Fri Nov 15, 7:17AM CST
The following issues have been halted by IIROC / L'OCRCVM a suspendu la negociation des titres suivants :

VentriPoint Diagnostics, Legend Gold and Black Iron Featured on Episode 18 of the Next Biggest Winner TV Show This Weekend
Marketwire - Thu Nov 14, 10:54AM CST
The Next Biggest Winner, a leading and nationally televised investment show focusing on small-cap and mid-cap companies, is pleased to announce Episode 18 will be airing across Canada this weekend.

Ventripoint Announces Increase and Closing Of Debenture Unit Private Placement
ACCESSWIRE - Tue Oct 22, 5:34PM CDT
Seattle, Washington, October 22, 2013 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation" (TSXV:VPT) is pleased to announce that it has increased its debenture unit placement from $300,000 to $500,000 and has completed its non-brokered private placement of debenture units of the Corporation previously announced on September 27, 2013 (the "Offering". The Corporation issued $500,000 in $1,000 principal amounts of convertible non-secured debentures ("Debentures", which shall mature three years from the date of issuance of the Debentures (the "Maturity Date", and issued a total of 2,500,000 common share purchase warrants with an exercise price of $0.15 for a period of three years. The Debentures shall bear a 12% annual simple interest calculated on the principal amount, with any accrued but unpaid interest under the Debentures due and payable on the anniversary of the Debenture in either cash or Common Shares (at the option of the Corporation) with the number of Common Shares being determined by using the 10 day volume-weighted average price of the Common Shares on the TSX Venture Exchange on that date that is five days prior to the anniversary date (subject to the approval of the TSX Venture Exchange). The Debentures may be converted by the holder at any time following the date of issuance at a price of $0.10 per share and the Debentures may be repaid partially, or in full, by the Corporation to any or all of the subscribers at any time without penalty.

Ventripoint Announces Closing of Private Placement
Marketwire - Mon Jul 29, 5:49PM CDT
Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company" (TSX VENTURE: VPT) (OTCQX: VPTDF) announces that it has completed the second closing of the second of its two previously announced non-brokered private placements.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hard Rock Tampa Bets $30 Million on Smoke-Free Play

Updated Category News Views 86

Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...

Continue Reading
Global-E Faces Fresh Scrutiny After Muted Quarterly Outlook

Updated Category News Views 39

A guidance bump that barely clears the curb can still wreck a stock. That is the unpleasant read-through from Global-E Online's third-quarter 2026 report: revenue guidance went higher, but not high enough to persuade investors that the business was pulling away from expectations. Shares fell after the release, and a securities-law investigation announced November 19 has...

Continue Reading
CMS Audit Proposal Reopens Medicare Advantage Risk

Updated Category News Views 104

A regulator just tossed a rusted anchor into managed care's earnings model. CMS's proposed Comprehensive Regulations to Uncover Suspicious Healthcare rule, dubbed CRUSH and numbered CMS-6098-P, puts Medicare Advantage risk-adjustment audits back at center stage. The headline nobody can casually wave away: audit findings from sampled enrollees could be extrapolated across...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 107

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 31

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 118

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 73

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
AV Access iDock B12 Chases the Growing Two-PC Desk Boom

Updated Category News Views 149

Cable spaghetti has become an oddly durable tax on anyone running a work laptop beside a gaming tower, and AV Access is taking a proper swing at it with the iDock B12. This is not some mystical new category; it is a KVM switch and docking station mashed together for a desk that has to serve two masters. Still, the company has aimed at the parts that usually get sacrificed...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 64

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Cash Flow Discipline Is Where Business Growth Gets Real

Updated Category News Views 55

A full order book can still leave a company gasping at payroll. That is the unglamorous point behind the Nov. 20, 2026, HelloNation piece featuring Kimberly Furrh of Furrh & Associates PC in Lawton, Oklahoma. Owners love to talk about sales because sales are visible, flattering and easy to celebrate. Cash is less theatrical. It is also the thing that keeps the lights on...

Continue Reading

Top 5 Most Recently Viewed Articles

Cathie Wood's Bold Investment in BitMine's Ethereum Strategy

Updated Category News Views 200

ARK Invest's Strategic Move ARK Invest, under the dynamic leadership of Cathie Wood, has taken a significant step by investing in BitMine Immersion Technologies Inc. The firm acquired nearly 4.8 million shares of BitMine, valued at an impressive $182 million through multiple ARK funds. Focus on Ethereum Acquisition This investment reflects BitMine's ambitious plan to...

Continue Reading
23andMe Advances Chapter 11 Plans with Court Approvals

Updated Category News Views 421

23andMe Secures Court Approval in Chapter 11 Process In a significant development, 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), recognized for its innovative approach in genetics and biotechnology, has received critical approvals from a Bankruptcy Court related to its Chapter 11 petitions. These petitions were filed, propelling the Company into a...

Continue Reading
Insights into Archer Aviation's Stock and Market Movements

Updated Category News Views 190

Understanding Archer Aviation's Stock Dynamics In a notable shift, investors with significant capital are displaying a bullish outlook on Archer Aviation. This uptrend is primarily highlighted by the option trading activities surrounding the company. Recent Option Trading Insights The latest data reveals that there have been 20 trades observed within Archer Aviation's...

Continue Reading
PACT Capital Partners Sets New Standards in Investment Strategies

Updated Category News Views 471

PACT Capital Partners Launches as an Independent Investment Firm PACT Capital LLC, known as PACT Capital Partners, has officially launched as a pioneering independent investment firm focused on empowering middle-market alternative asset managers. With significant backing from major players, the firm aims to carve a niche in the competitive investment landscape. Strategic...

Continue Reading
Bakery Mixes Forecast 2026-2036: Growth and Trends

Updated Category News Views 61

Standardization Taking Center Stage in Bakery Mixes Imagine a bustling bakery floor, with the smell of fresh bread wafting through the air. Yet behind the scenes lies a streamlined operation driven by pre-formulated mixes, which is exactly where the global bakery mixes market finds its muscle these days. Valued at $6.5 billion in 2025, the market has its sights set on...

Continue Reading